| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |